RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $378,929 | -30.6% | 45,057 | +3.7% | 0.00% | -33.3% |
| Q2 2023 | $545,795 | -19.3% | 43,455 | +5.8% | 0.00% | -25.0% |
| Q1 2023 | $676,604 | +12.5% | 41,081 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $601,529 | -25.9% | 40,263 | +10.9% | 0.00% | -33.3% |
| Q3 2022 | $812,000 | +35.3% | 36,319 | +1.4% | 0.01% | +50.0% |
| Q2 2022 | $600,000 | -42.3% | 35,807 | +3.1% | 0.00% | -33.3% |
| Q1 2022 | $1,040,000 | -8.9% | 34,738 | -6.6% | 0.01% | 0.0% |
| Q4 2021 | $1,142,000 | +10.2% | 37,184 | +13.2% | 0.01% | 0.0% |
| Q3 2021 | $1,036,000 | -13.7% | 32,856 | +0.2% | 0.01% | +50.0% |
| Q2 2021 | $1,200,000 | +29.9% | 32,803 | +22.7% | 0.00% | +33.3% |
| Q1 2021 | $924,000 | +18.8% | 26,725 | +42.8% | 0.00% | 0.0% |
| Q4 2020 | $778,000 | -5.1% | 18,709 | -2.8% | 0.00% | -25.0% |
| Q3 2020 | $820,000 | – | 19,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |